Hutchmed China to shift strategy toward advanced assets in pipeline
Hutchmed Ltd announced on Tuesday it will shift focus towards its most advanced assets from its internal developed pipeline, following an evaluation of the business. The biopharmaceutical company... | November 15, 2022
Source: marketscreener.com